TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. BIOPHARMACEUTICALS MARKET, BY TYPE (USD BILLION)
6.1. Monoclonal Antibodies
6.2. Recombinant Proteins
6.3. Vaccines
6.4. Gene Therapy
6.5. Cell Therapy
7. BIOPHARMACEUTICALS MARKET, BY APPLICATION (USD BILLION)
7.1. Oncology
7.2. Metabolic Disorders
7.3. Infectious Diseases
7.4. Cardiovascular Diseases
7.5. Neurological Disorders
8. BIOPHARMACEUTICALS MARKET, BY END USE (USD BILLION)
8.1. Hospitals
8.2. Research Institutions
8.3. Pharmaceutical Companies
8.4. Biotechnology Companies
9. BIOPHARMACEUTICALS MARKET, BY PRODUCTION TECHNOLOGY (USD BILLION)
9.1. Cell Culture
9.2. Fermentation
9.3. Purification
9.4. Filtration
9.5. Lyophilization
10. BIOPHARMACEUTICALS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Biopharmaceuticals Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Biopharmaceuticals Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. BristolMyers Squibb
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Sanofi
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Takeda Pharmaceutical
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Eli Lilly and Company
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Regeneron Pharmaceuticals
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Celgene
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. AbbVie
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Gilead Sciences
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Amgen
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Johnson and Johnson
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Pfizer
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Roche
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Biogen
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Merck and Co
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Novartis
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 9. US BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 10. US BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 11. US BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 30. UK BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 31. UK BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 59. APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 60. APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 61. APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 129. MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 130. MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 131. MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCTION TECHNOLOGY, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA BIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 3. US BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 4. US BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 5. US BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 6. US BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 7. US BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 9. CANADA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 10. CANADA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 11. CANADA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 12. CANADA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE BIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 14. GERMANY BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 15. GERMANY BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 16. GERMANY BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 17. GERMANY BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 18. GERMANY BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 20. UK BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 21. UK BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 22. UK BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 23. UK BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 25. FRANCE BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 26. FRANCE BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 27. FRANCE BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 28. FRANCE BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 30. RUSSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 31. RUSSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 32. RUSSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 33. RUSSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 35. ITALY BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 36. ITALY BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 37. ITALY BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 38. ITALY BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 40. SPAIN BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 41. SPAIN BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 42. SPAIN BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 43. SPAIN BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 45. REST OF EUROPE BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 46. REST OF EUROPE BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 47. REST OF EUROPE BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 48. REST OF EUROPE BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC BIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 50. CHINA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 51. CHINA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 52. CHINA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 53. CHINA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 54. CHINA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 56. INDIA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 57. INDIA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 58. INDIA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 59. INDIA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 61. JAPAN BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 62. JAPAN BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 63. JAPAN BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 64. JAPAN BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 66. SOUTH KOREA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 67. SOUTH KOREA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 68. SOUTH KOREA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 69. SOUTH KOREA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 71. MALAYSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 72. MALAYSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 73. MALAYSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 74. MALAYSIA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 76. THAILAND BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 77. THAILAND BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 78. THAILAND BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 79. THAILAND BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 81. INDONESIA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 82. INDONESIA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 83. INDONESIA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 84. INDONESIA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 86. REST OF APAC BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 87. REST OF APAC BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 88. REST OF APAC BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 89. REST OF APAC BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 91. BRAZIL BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 92. BRAZIL BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 93. BRAZIL BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 94. BRAZIL BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 95. BRAZIL BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 97. MEXICO BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 98. MEXICO BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 99. MEXICO BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 100. MEXICO BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 102. ARGENTINA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 103. ARGENTINA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 104. ARGENTINA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 105. ARGENTINA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 107. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 108. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 109. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 110. REST OF SOUTH AMERICA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA BIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 113. GCC COUNTRIES BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 114. GCC COUNTRIES BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 115. GCC COUNTRIES BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 116. GCC COUNTRIES BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 118. SOUTH AFRICA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 119. SOUTH AFRICA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 120. SOUTH AFRICA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 121. SOUTH AFRICA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA BIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 123. REST OF MEA BIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 124. REST OF MEA BIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 125. REST OF MEA BIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
FIGURE 126. REST OF MEA BIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF BIOPHARMACEUTICALS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF BIOPHARMACEUTICALS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: BIOPHARMACEUTICALS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: BIOPHARMACEUTICALS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: BIOPHARMACEUTICALS MARKET
FIGURE 133. BIOPHARMACEUTICALS MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 134. BIOPHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 136. BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 137. BIOPHARMACEUTICALS MARKET, BY END USE, 2024 (% SHARE)
FIGURE 138. BIOPHARMACEUTICALS MARKET, BY END USE, 2019 TO 2032 (USD Billions)
FIGURE 139. BIOPHARMACEUTICALS MARKET, BY PRODUCTION TECHNOLOGY, 2024 (% SHARE)
FIGURE 140. BIOPHARMACEUTICALS MARKET, BY PRODUCTION TECHNOLOGY, 2019 TO 2032 (USD Billions)
FIGURE 141. BIOPHARMACEUTICALS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. BIOPHARMACEUTICALS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
